Cimzia, solution injectable

7680600960015 CH-60096 Injektionslösung

Associated product:

CIMZIA sol inj 200 mg/ml 2 ser pré 1 ml
Cimzia, solution injectable
Cimzia, solution injectable
Cimzia, solution injectable
1 / 3
google

Article details

Package size
2
Selling units
2
Measure
Spritze(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
08/01/2025
Patient information leaflet
Français
08/01/2025
Patient information leaflet
Italien
08/01/2025
Summary of Product Characteristics
Allemand
08/01/2025
Summary of Product Characteristics
Français
08/01/2025
Summary of Product Characteristics
Italien
08/01/2025

Detailed composition

Substance Quantity Type Category
(N/A)
200.0 MG Substance Wirkstoff (Principe actif)
TEL
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
3.257 MG Substance HBESI

Reimbursement information

Public price
CHF 986.50
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/08/2010

Authorization holder

UCB-Pharma SA

1630 Bulle

Authorization information

Swissmedic authorization number
60096
Drug name
Cimzia, solution injectable
Galenic form
LSPA
ATC Code
L04AB05
Authorization status
Z
Dispensing category
B
First authorization
11/06/2010
Authorization expiration date
31/12/9999
IT Number
07.15.0.
Domain
Human medicine
Field of application
Morbus Crohn, Rheumatoide Arthritis, Psoriatische Arthritis, axiale Spondyloarthritis inkl. ankylosierende Spondylitis und nicht-röntgenologische axiale Spondyloarthritis, Plaque Psoriasis be Erwachsenen

Package details

Description (FR)
CIMZIA sol inj 200 mg/ml 2 ser pré 1 ml
Description (DE)
CIMZIA Inj Lös 200 mg/ml 2 Fertspr 1 ml
Market launch
11/06/2010
Narcotic (BTM)
No

Other package sizes (1)

None
2 SPRI
GTIN: None
Not in V1